Diabetes Therapy
Candesartan protects beta-cell function in diabetes mouse model
Published in Obesity and Diabetes Week, July 10th, 2006
"Several epidemiological studies suggested that treatment with angiotensin II type 1 receptor blocker (ARB) provided a risk reduction of developing type 2 diabetes. In this study, we investigated whether and how ARB treatment can improve abnormalities of pancreatic islets in diabetes state," scientists writing in the journal Biochemical and Biophysical Research Communications report.
J.Q. Shao and colleagues at Juntendo University explained, "We randomized db/db mice, a model of type 2 diabetes with obesity, at the age of 8 weeks to receive...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Diabetes Therapy
Estradiol improves glucose tolerance and insulin sensitivity in ob/ob mice - Obesity & Diabetes Pathogenesis
Fat and glucose regulate pyruvate dehydrogenase kinase mRNA in pancreatic islets - Obesity Epidemiology
Prenatal nutrition shapes obesity risk through changes in leptin sensitivity - Obesity Pathogenesis
Inhibin beta B expression is high in adipocytes and may correlate to metabolic disease risk - Adenocarcinomas
High body mass index increases adenocarcinoma risk in the esophagus or gastric cardia - Angiography & Diabetes
Acetylcysteine provides no added benefit in diabetes patients with coronary angiography - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
